MetaVia (MTVA) Current Leases (2019 - 2026)
MetaVia's (MTVA) quarterly Current Leases came in at $68000.0 in Q4 2025, down 12.82% YoY from $78000.0 in Q4 2024, and down 13.92% on a QoQ basis from $79000.0 in Q3 2025.
MetaVia (MTVA) Current Leases (2019 - 2026) Analysis & Trends
MetaVia (MTVA) has 7 years of Current Leases data on file, last reported at $68000.0 in Q4 2025.
- Quarterly Current Leases fell 12.82% year-over-year to $68000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $68000.0 (down 12.82% YoY) and the FY2025 annual result came in at $68000.0, down 12.82% from the prior year.
- Current Leases retreated to $68000.0 in Q4 2025, from $79000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $83000.0 in Q2 2025 to a low of $24000.0 in Q1 2021.
- A 5-year average of $57733.3 and a median of $68000.0 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases grew 16.42% — and 2025, when it slipped 12.82%.
- Tracing MTVA's Current Leases over 5 years: stood at $26000.0 in 2021, then advanced by 3.85% to $27000.0 in 2022, then surged by 148.15% to $67000.0 in 2023, then rose by 16.42% to $78000.0 in 2024, then fell by 12.82% to $68000.0 in 2025.
- The last three Current Leases figures came in at $68000.0 (Q4 2025), $79000.0 (Q3 2025), and $83000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | 74,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74,000.00 |
| Dec 31, 2025 | 68,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 72,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 67,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 26,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Dec 31, 2020 | 24,000.00 |
| Sep 30, 2020 | 23,000.00 |
| Jun 30, 2020 | 23,000.00 |
| Mar 31, 2020 | 22,000.00 |